https://medicaex.com/prnewswire/plastic-threatens-human-and-planetary-health/ 2023-03-21T09:12:12+00:00 https://medicaex.com/prnewswire/hovione-and-ripple-enter-strategic-partnership-to-expand-epidel-platform-into-non-ophthalmic-space/ 2023-03-21T08:12:17+00:00 https://medicaex.com/prnewswire/well-commune-shenton-is-the-new-wellness-space-for-all-from-27th-march-to-30-april-2023/ 2023-03-21T08:12:11+00:00 https://medicaex.com/prnewswire/jacobio-pharma-to-present-data-of-three-preclinical-studies-at-the-2023-aacr-annual-meeting/ 2023-03-21T07:12:26+00:00 https://medicaex.com/prnewswire/building-back-helping-young-people-go-from-recovery-to-discovery/ 2023-03-21T07:12:16+00:00 https://medicaex.com/prnewswire/cney-wins-a-large-activated-carbon-order/ 2023-03-21T06:12:18+00:00 https://medicaex.com/prnewswire/health-food-symmetry-has-formed-a-strategic-alignment-with-sunrise-health-wellness-launching-new-products-at-the-2023-australian-pharmacy-professional-conference-trade-exhibition-gold-coa/ 2023-03-21T06:12:17+00:00 https://medicaex.com/prnewswire/i-mab-to-report-full-year-2022-financial-results-and-provide-corporate-update-on-march-31-2023/ 2023-03-21T05:12:18+00:00 https://medicaex.com/prnewswire/robooter-to-showcases-multiple-products-at-naidex-under-the-theme-of-reboot-your-life/ 2023-03-21T03:12:11+00:00 https://medicaex.com/prnewswire/deepcare-debuts-at-ids-cologne-2023/ 2023-03-20T17:12:23+00:00 https://medicaex.com/prnewswire/320-world-oral-health-day-lifting-the-mask-mandate-maintaining-good-oral-hygiene-and-flashing-a-healthy-and-confident-smile/ 2023-03-20T17:12:17+00:00 https://medicaex.com/prnewswire/austco-augments-industry-leading-nurse-call-and-healthcare-communications-solutions-with-4d-imaging-radar-fall-detection-by-vayyar/ 2023-03-20T13:12:25+00:00 https://medicaex.com/prnewswire/nmpa-accepted-the-registration-applications-for-uro-g-and-uro-3500/ 2023-03-20T13:12:21+00:00 https://medicaex.com/prnewswire/fdi-world-dental-federation-calls-for-global-leaders-to-prioritise-action-against-oral-diseases-at-major-un-meeting-on-health/ 2023-03-20T13:12:13+00:00 https://medicaex.com/prnewswire/samsung-biologics-announces-construction-of-plant-5-to-commence-bio-campus-ii-capacity-expansion/ 2023-03-20T12:12:18+00:00 https://medicaex.com/prnewswire/ascentage-pharma-to-present-latest-results-from-three-preclinical-studies-at-2023-american-association-for-cancer-research-annual-meeting/ 2023-03-20T07:12:29+00:00 https://medicaex.com/prnewswire/qritive-launches-qai-prostate-advanced-ai-powered-prostate-cancer-diagnosis-tool-for-pathologists/ 2023-03-20T02:12:27+00:00 https://medicaex.com/prnewswire/chinas-first-personalized-neoantigen-targeted-cancer-vaccine-receives-nmpas-clinical-trial-approval/ 2023-03-20T02:12:20+00:00 https://medicaex.com/prnewswire/success-for-surglasses-technology-first-ar-surgery-completed-in-the-united-states/ 2023-03-20T01:12:28+00:00 https://medicaex.com/prnewswire/ys-biopharma-to-ring-the-opening-bell-and-debut-on-nasdaq/ 2023-03-20T01:12:22+00:00 https://medicaex.com/prnewswire/izokibep-phase-2b-3-hidradenitis-suppurative-data-presented-at-the-2023-american-academy-of-dermatology-annual-meeting/ 2023-03-20T01:12:21+00:00 https://medicaex.com/prnewswire/amgen-and-nsg-biolabs-announce-albatroz-therapeutics-as-winner-of-first-amgen-golden-ticket-in-singapore/ 2023-03-20T01:12:21+00:00 https://medicaex.com/prnewswire/fda-approves-expanded-indication-for-telixs-illuccix-to-include-patient-selection-for-psma-directed-radioligand-therapy-2/ 2023-03-20T00:12:19+00:00 https://medicaex.com/prnewswire/cgtn-china-achieves-major-decisive-victory-in-covid-19-response-cpc-leadership/ 2023-03-19T07:12:14+00:00 https://medicaex.com/prnewswire/mabwell-launched-first-in-human-clinical-trial-of-its-iron-homeostasis-regulating-macromolecular-drug-9mw3011/ 2023-03-18T00:12:29+00:00 https://medicaex.com/prnewswire/tetracore-announces-usda-purchase-of-asf-and-fmd-diagnostic-test-kits/ 2023-03-17T20:12:15+00:00 https://medicaex.com/prnewswire/simcere-zaiming-announces-clinical-collaboration-to-evaluate-sim0235-a-tnfr2-monoclonal-antibody-in-combination-with-keytruda-pembrolizumab-in-a-phase-1-trial-in-advanced-solid-tumors-and-cu/ 2023-03-17T13:12:33+00:00 https://medicaex.com/prnewswire/patient-enrollment-completed-for-phase-iii-clinical-trial-of-akesos-cadonilimab-in-treatment-of-gastric-cancer/ 2023-03-17T13:12:33+00:00 https://medicaex.com/prnewswire/everest-medicines-announces-approval-of-xerava-in-china-for-the-treatment-of-complicated-intra-abdominal-infections-in-adult-patients/ 2023-03-17T13:12:22+00:00 https://medicaex.com/prnewswire/bolstering-healthcare-quality-in-malaysia-with-renowned-flagship-hospitals/ 2023-03-17T13:12:22+00:00 https://medicaex.com/prnewswire/servier-announces-partnership-with-qiagen-to-develop-new-midh1-companion-diagnostic-test-to-support-serviers-onco-hematology-portfolio/ 2023-03-17T11:12:26+00:00 https://medicaex.com/prnewswire/the-fda-has-approved-the-csf-1r-inhibitor-pimicotinib-absk021-of-abbisko-therapeutics-to-enter-the-pivotal-global-multi-center-phase-iii-clinical-trial/ 2023-03-17T11:12:20+00:00 https://medicaex.com/prnewswire/alphamab-oncology-announces-the-first-patient-dosed-in-the-phase-i-trial-of-anti-her2-bispecific-adc-jskn003/ 2023-03-17T11:12:20+00:00 https://medicaex.com/prnewswire/waterdrop-inc-announces-fourth-quarter-and-fiscal-year-2022-unaudited-financial-results/ 2023-03-17T11:12:14+00:00 https://medicaex.com/prnewswire/waterdrop-announces-certain-board-and-executive-changes/ 2023-03-17T11:12:14+00:00 https://medicaex.com/prnewswire/uniontech-showcases-dental-3d-printer-s300-at-ids-2023-international-dental-show-in-cologne-germany/ 2023-03-17T11:12:14+00:00 https://medicaex.com/prnewswire/antengene-announces-ind-approval-for-the-phase-i-clinch-trial-of-atg-022-claudin-18-2-adc-for-the-treatment-of-advanced-or-metastatic-solid-tumors-in-china/ 2023-03-17T10:12:29+00:00 https://medicaex.com/prnewswire/digital-therapeutics-startup-respiree-gains-us-fda-clearance-for-its-rs001-cardio-respiratory-wearable/ 2023-03-17T10:12:24+00:00 https://medicaex.com/prnewswire/well-medical-partners-which-owns-and-manages-a-clinic-partnered-with-care-a-web3-medical-project-partners-with-jmhc-jtbs-dedicated-medical-tourism-section/ 2023-03-17T10:12:19+00:00 https://medicaex.com/prnewswire/fda-approves-expanded-indication-for-telixs-illuccix-to-include-patient-selection-for-psma-directed-radioligand-therapy/ 2023-03-17T06:12:18+00:00 https://medicaex.com/prnewswire/oral-care-brand-bitvae-celebrates-world-oral-health-day-with-a-collection-of-high-quality-easy-to-use-products-accessible-to-all/ 2023-03-17T06:12:12+00:00 https://medicaex.com/prnewswire/axa-study-1-out-of-5-people-in-hong-kong-feel-they-are-flourishing/ 2023-03-17T02:12:13+00:00 https://medicaex.com/prnewswire/telixs-zircon-phase-iii-kidney-cancer-imaging-study-presented-in-game-changing-session-at-eau/ 2023-03-17T01:12:27+00:00 https://medicaex.com/prnewswire/akeso-reported-2022-annual-results/ 2023-03-17T01:12:16+00:00 https://medicaex.com/prnewswire/porton-advanced-and-bennu-biotherapeutics-announced-a-strategic-partnership-to-accelerate-cell-therapy-development-for-solid-tumors/ 2023-03-16T13:12:28+00:00 https://medicaex.com/prnewswire/turtletree-debuts-first-ever-animal-free-lactoferrin-one-of-milks-most-valuable-and-functional-proteins-in-world-first-tasting/ 2023-03-16T13:12:13+00:00 https://medicaex.com/prnewswire/lunit-to-present-5-abstracts-at-the-2023-aacr-annual-meeting/ 2023-03-16T12:12:19+00:00 https://medicaex.com/prnewswire/everest-medicines-to-announce-full-year-2022-financial-results-on-march-31-2023/ 2023-03-16T08:12:18+00:00 https://medicaex.com/prnewswire/hanall-biopharma-opens-applications-for-the-2023-pharmaceutical-industry-fellowship-program/ 2023-03-16T02:12:23+00:00 https://medicaex.com/prnewswire/ark-biopharmaceutical-and-calibr-a-division-of-scripps-research-announce-co-development-collaboration-on-ak0705-a-potential-first-in-class-drug-for-treating-a-broad-spectrum-of-respiratory-disease/ 2023-03-16T00:12:16+00:00 https://medicaex.com/prnewswire/alphamab-oncology-to-present-the-preclinical-results-of-pd-l1-ox40-bispecific-antibody-kn052-at-aacr-2023/ 2023-03-16T00:12:16+00:00 https://medicaex.com/prnewswire/kpc-lyfe-acquires-bikram-yoga/ 2023-03-15T19:12:10+00:00 https://medicaex.com/prnewswire/cstone-pharmaceuticals-reports-2022-annual-results-and-business-updates/ 2023-03-15T15:12:17+00:00 https://medicaex.com/prnewswire/zhongchao-inc-releases-survey-results-for-bone-marrow-cancer-patient-services-with-more-than-80-patients-indicating-full-satisfaction/ 2023-03-15T13:12:28+00:00 https://medicaex.com/prnewswire/ys-biopharma-and-summit-healthcare-announce-shareholder-approval-of-business-combination/ 2023-03-15T13:12:18+00:00 https://medicaex.com/prnewswire/medical-tourism-moonshot-breaking-the-barriers-to-quality-healthcare/ 2023-03-15T13:12:18+00:00 https://medicaex.com/prnewswire/over-1000-patients-enrolled-in-landmark-selution-denovo-study/ 2023-03-15T13:12:12+00:00 https://medicaex.com/prnewswire/u-s-government-and-novavax-extend-partnership-securing-up-to-1-5-million-additional-doses-of-novavax-covid-19-vaccine/ 2023-03-15T12:12:15+00:00 https://medicaex.com/prnewswire/prenetics-announces-fourth-quarter-and-full-year-2022-financial-results/ 2023-03-15T11:12:17+00:00 https://medicaex.com/prnewswire/allorion-therapeutics-a-next-generation-precision-medicine-company-focusing-on-oncology-and-autoimmune-diseases-raises-50-million-series-b-financing/ 2023-03-15T10:12:27+00:00 https://medicaex.com/prnewswire/sap-introduces-sap-datasphere-to-simplify-customers-data-landscape/ 2023-03-15T07:12:14+00:00 https://medicaex.com/prnewswire/nippon-express-belgium-joins-pharma-aero/ 2023-03-15T07:12:14+00:00 https://medicaex.com/prnewswire/genfleet-therapeutics-to-present-phase-i-data-for-gfh312-at-2023-american-society-for-clinical-pharmacology-therapeutics-meeting/ 2023-03-15T02:12:25+00:00 https://medicaex.com/prnewswire/ajinomoto-bio-pharma-services-awarded-three-cdmo-leadership-awards/ 2023-03-15T02:12:16+00:00 https://medicaex.com/prnewswire/estrella-biopharma-announces-fda-clearance-of-ind-application-for-phase-i-ii-clinical-trial-starlight-1-of-eb103-a-cd19-targeted-artemis-t-cell-therapy-to-patients-with-b-cell-lymphomas/ 2023-03-15T00:12:29+00:00 https://medicaex.com/prnewswire/oneday-biotech-to-unveil-one-drilling-system-at-ids-2023/ 2023-03-14T22:12:24+00:00 https://medicaex.com/prnewswire/telix-to-showcase-additional-zircon-phase-iii-data-in-kidney-cancer-imaging-and-theranostic-pipeline-developments-at-eau/ 2023-03-14T15:12:26+00:00 https://medicaex.com/prnewswire/everest-medicines-announces-partner-calliditas-therapeutics-reports-positive-topline-results-from-phase-3-nefigard-trial-evaluating-nefecon-in-iga-nephropathy/ 2023-03-14T15:12:18+00:00 https://medicaex.com/prnewswire/picarros-new-1-ppb-class-chemical-metrology-solution-for-lithography-process-tool-monitoring-enables-semiconductor-fabs-to-improve-process-control/ 2023-03-14T15:12:11+00:00 https://medicaex.com/prnewswire/usaid-funded-project-recognizes-eight-organizations-for-leadership-in-adopting-antimicrobial-use-stewardship-principles/ 2023-03-14T14:12:12+00:00 https://medicaex.com/prnewswire/japans-saitama-medical-university-international-medical-center-joins-the-trinetx-network-to-study-global-real-world-data-on-rare-diseases-treatments-and-outcomes-to-benefit-its-patients/ 2023-03-14T12:12:26+00:00 https://medicaex.com/prnewswire/argon-medical-devices-modernizes-portal-vein-access-with-the-launch-of-the-traveler-series/ 2023-03-14T12:12:22+00:00 https://medicaex.com/prnewswire/annji-pharmaceutical-announced-licensing-agreement-with-avenue-therapeutics-to-develop-and-commercialize-aj201-a-first-in-class-clinical-asset-for-the-kennedys-disease-treatment/ 2023-03-14T12:12:16+00:00 https://medicaex.com/prnewswire/anpac-bio-announces-receipt-of-the-first-payment-from-a-malaysia-customer-on-a-signed-us1-5-million-cancer-detection-equipment-purchase-contract/ 2023-03-14T10:12:20+00:00 https://medicaex.com/prnewswire/ping-an-health-achieves-enhancement-in-managed-care-healthcare/ 2023-03-14T10:12:15+00:00 https://medicaex.com/prnewswire/so-young-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-21-2023/ 2023-03-14T10:12:10+00:00 https://medicaex.com/prnewswire/genscript-probio-congratulates-eutilexs-ind-clearance-from-mfds/ 2023-03-14T09:12:25+00:00 https://medicaex.com/prnewswire/annabella-the-first-breast-pump-to-simulate-a-babys-tongue-was-launched-in-israel-taking-an-estimated-10-of-the-monthly-israeli-breast-pump-market-in-february-the-company-is-raising-funds-to-a/ 2023-03-14T09:12:16+00:00 https://medicaex.com/prnewswire/osano-debuts-latest-products-at-cosmoprof-2023/ 2023-03-14T09:12:11+00:00 https://medicaex.com/prnewswire/medlab-asia-and-asia-health-returns-to-thailand-after-securing-deals-worth-us35m-in-2022/ 2023-03-14T08:12:21+00:00 https://medicaex.com/prnewswire/patient-enrollment-completed-for-the-phase-3-trial-of-boan-biotechs-aflibercept-intravitreous-injection-in-china/ 2023-03-14T08:12:16+00:00 https://medicaex.com/prnewswire/hummingbird-bioscience-exercises-its-option-to-license-the-clinical-trial-results-from-cancer-research-uk-to-support-further-development-of-hmbd-001/ 2023-03-14T04:12:55+00:00 https://medicaex.com/prnewswire/beyond-expo-back-in-macao-for-2023-to-see-technology-redefined-in-one-of-asias-biggest-tech-events/ 2023-03-14T02:12:11+00:00 https://medicaex.com/prnewswire/qritive-and-corista-announce-partnership-to-advance-the-use-of-computational-digital-pathology-workflows-with-integrated-image-management/ 2023-03-14T01:12:14+00:00 https://medicaex.com/prnewswire/everest-medicines-announces-silicon-valley-bank-developments-have-minimal-impact-on-company/ 2023-03-13T22:12:15+00:00 https://medicaex.com/prnewswire/hanall-biopharmas-licensed-partner-in-china-announces-positive-topline-phase-3-results-for-batoclimab-in-myasthenia-gravis/ 2023-03-13T21:12:25+00:00 https://medicaex.com/prnewswire/annji-pharmaceutical-announced-a-licensing-agreement-with-avenue-therapeutics-to-develop-and-commercialize-aj201-a-first-in-class-clinical-asset-for-the-treatment-of-kennedys-disease/ 2023-03-13T21:12:15+00:00 https://medicaex.com/prnewswire/austco-augments-industry-leading-nurse-call-and-healthcare-communications-solutions-with-4d-imaging-radar-fall-detection-by-vayyar-2/ 2023-03-13T16:12:15+00:00 https://medicaex.com/prnewswire/apollo-hospitals-group-completes-500-pediatric-liver-transplants/ 2023-03-13T14:12:11+00:00 https://medicaex.com/prnewswire/hugel-nominates-suk-yong-cha-as-non-executive-director/ 2023-03-13T13:12:19+00:00 https://medicaex.com/prnewswire/ncoda-international-executive-council-to-advance-medically-integrated-oncology-worldwide/ 2023-03-13T13:12:19+00:00 https://medicaex.com/prnewswire/harbour-biomed-announces-positive-topline-results-from-phase-iii-trial-of-batoclimab-for-treatment-of-generalized-myasthenia-gravis/ 2023-03-13T12:12:26+00:00 https://medicaex.com/prnewswire/alnylam-pharmaceuticals-and-medison-pharma-announce-the-expansion-of-their-collaboration-to-a-multi-regional-partnership-to-commercialize-rnai-therapeutics/ 2023-03-13T12:12:17+00:00 https://medicaex.com/prnewswire/world-first-45000-patients-study-to-develop-ai-based-precision-medicine-for-migraine-relief-collaboration-between-healint-and-university-of-geneva-switzerland/ 2023-03-13T12:12:17+00:00 https://medicaex.com/prnewswire/confirmatory-clinical-trial-of-liwen-rf-ablation-system-in-china-concluded/ 2023-03-13T06:12:21+00:00 https://medicaex.com/prnewswire/nippon-express-holdings-strengthens-pharmaceutical-logistics-quality-system-globally/ 2023-03-13T06:12:15+00:00 https://medicaex.com/prnewswire/ulab-systems-launches-ai-platform-innovations-and-receives-superior-ratings-for-its-uassist-treatment-planning-assistance-service/ 2023-03-12T23:12:10+00:00 https://medicaex.com/prnewswire/clinique-la-prairie-japan-and-5-stars-medical-club-begin-a-business-partnership/ 2023-03-10T11:12:16+00:00 https://medicaex.com/prnewswire/us-proteomics-sector-set-for-shake-up-as-new-ionopticks-tech-unveiled/ 2023-03-10T08:12:23+00:00 https://medicaex.com/prnewswire/safeguard-children-of-the-stars-soul-apps-new-campaign-inspires-young-users/ 2023-03-10T04:12:09+00:00 https://medicaex.com/prnewswire/chamlion-the-worlds-first-dental-3d-printing-service-cloud-platform-will-appear-at-the-ids/ 2023-03-10T01:12:10+00:00 https://medicaex.com/prnewswire/medit-launches-new-occlusion-analyzer-app-for-quick-and-easy-analysis/ 2023-03-09T22:12:10+00:00 https://medicaex.com/prnewswire/havas-health-you-launches-dynamic-value-and-access-consultancy-archipelago/ 2023-03-09T15:12:12+00:00 https://medicaex.com/prnewswire/biorchestra-participating-in-two-upcoming-therapeutic-rna-focused-events/ 2023-03-09T12:12:19+00:00 https://medicaex.com/prnewswire/waterdrop-inc-to-report-fourth-quarter-and-fiscal-year-2022-financial-results-on-march-17-2023/ 2023-03-09T12:12:12+00:00 https://medicaex.com/prnewswire/singleron-biotechnologies-and-macrogen-europe-announce-a-strategic-alliance/ 2023-03-09T11:12:29+00:00 https://medicaex.com/prnewswire/hovione-receives-the-2023-cdmo-leadership-award-in-all-six-categories-and-is-champion-in-compatibility-and-expertise/ 2023-03-09T11:12:20+00:00 https://medicaex.com/prnewswire/affamed-technologies-announces-the-first-implantation-in-the-china-registrational-clinical-trial-of-mini-well-the-progressive-extended-depth-of-focus-iol/ 2023-03-09T06:12:25+00:00 https://medicaex.com/prnewswire/grand-launching-of-dnatest-id-a-comprehensive-dna-test-in-indonesia/ 2023-03-09T03:12:10+00:00 https://medicaex.com/prnewswire/msci-esg-updated-i-mab-to-a-rating/ 2023-03-09T01:12:18+00:00 https://medicaex.com/prnewswire/neurophet-to-unveil-new-technology-for-analyzing-aria-side-effect-at-ecr-2023/ 2023-03-09T00:12:22+00:00 https://medicaex.com/prnewswire/six-of-the-top-20-pharma-select-veeva-vault-edc-as-company-standard-for-new-trials/ 2023-03-08T21:12:29+00:00 https://medicaex.com/prnewswire/airs-medical-applauded-by-frost-sullivan-for-reducing-mri-equipments-exam-wait-times-with-its-swiftmr-technology/ 2023-03-08T21:12:24+00:00 https://medicaex.com/prnewswire/medtec-china-2023-will-be-held-on-june-1-3-2023-in-suzhou-china/ 2023-03-08T20:12:27+00:00 https://medicaex.com/prnewswire/ceva-sante-animale-calls-to-speed-up-development-of-critical-new-vaccines-at-viv-asia-2023/ 2023-03-08T20:12:17+00:00 https://medicaex.com/prnewswire/decipher-fat-burning-a-breath-analyzer-achieved-funding-goal-on-indiegogo-in-1-hour/ 2023-03-08T17:12:11+00:00 https://medicaex.com/prnewswire/jw-therapeutics-announces-initiation-of-clinical-study-of-carteyva-in-first-line-treatment-in-patients-with-high-risk-large-b-cell-lymphoma/ 2023-03-08T10:12:27+00:00 https://medicaex.com/prnewswire/pierre-fabre-pursues-its-commitment-against-rare-diseases-in-the-pediatric-oncology-and-dermatology-fields/ 2023-03-08T09:12:16+00:00 https://medicaex.com/prnewswire/icp-das-bmp-to-show-kimes-2023-visitors-high-performance-medical-tpu-pellets-in-seoul-korea/ 2023-03-08T07:12:11+00:00 https://medicaex.com/prnewswire/clinchoice-acquires-cromsource-expanding-its-global-presence/ 2023-03-07T23:12:22+00:00 https://medicaex.com/prnewswire/digital-transformation-across-life-sciences-industry-boosts-instrumentation-market/ 2023-03-07T17:12:24+00:00 https://medicaex.com/prnewswire/the-next-generation-of-smart-home-gym-kickstarter-success-hookee-to-launch-the-indiegogo-campaign/ 2023-03-07T14:12:12+00:00 https://medicaex.com/prnewswire/wat-med-initiates-collaborative-research-study-with-the-ohio-state-university-to-test-the-effectiveness-of-emeterm-neuromodulation-technology-to-manage-nausea-and-vomiting/ 2023-03-07T08:12:29+00:00 https://medicaex.com/prnewswire/results-of-cldn18-2-targeting-immuno-pet-probe-for-non-invasive-imaging-in-gastrointestinal-tumors-published/ 2023-03-07T08:12:21+00:00 https://medicaex.com/prnewswire/oscotec-announces-topline-results-for-phase-2-trial-of-cevidoplenib/ 2023-03-07T05:12:30+00:00 https://medicaex.com/prnewswire/rayence-unveils-the-first-x-ray-detector-technology-utilizing-spad-technology/ 2023-03-07T02:12:32+00:00 https://medicaex.com/prnewswire/porton-advanced-collaborates-with-danausgt-to-accelerate-the-development-of-gene-and-cell-therapy/ 2023-03-07T02:12:21+00:00 https://medicaex.com/prnewswire/appian-and-roboyo-help-primary-health-tasmania-achieve-better-community-health-and-wellbeing-outcomes/ 2023-03-06T23:12:11+00:00 https://medicaex.com/prnewswire/siyi-intelligence-raises-nearly-15-million-in-series-a-financing/ 2023-03-06T15:12:12+00:00 https://medicaex.com/prnewswire/anpac-bio-medical-science-announces-us5-million-private-placement/ 2023-03-06T14:12:15+00:00 https://medicaex.com/prnewswire/altos-biologics-a-subsidiary-of-alteogen-completed-patient-enrollment-in-global-phase-3-clinical-trial-of-eylea-biosimilar-in-neovascular-age-related-macular-degeneration/ 2023-03-06T13:12:32+00:00 https://medicaex.com/prnewswire/prenetics-announces-formation-of-scientific-advisory-board-to-support-new-business-strategy-in-precision-oncology/ 2023-03-06T13:12:21+00:00 https://medicaex.com/prnewswire/anpac-bio-announces-positive-results-from-its-multi-year-and-multi-cancer-test-follow-up-study/ 2023-03-06T12:12:32+00:00 https://medicaex.com/prnewswire/vieworks-vivix-x-ray-flat-panel-detector-full-line-up-to-be-showcased-at-ecr-2023/ 2023-03-06T10:12:26+00:00 https://medicaex.com/prnewswire/abbisko-therapeutics-announces-an-out-license-agreement-with-allist-for-abk3376/ 2023-03-06T10:12:20+00:00 https://medicaex.com/prnewswire/fapon-biopharmas-anti-cd47-antibody-fp002-earns-ind-approval-from-fda/ 2023-03-06T06:12:27+00:00 https://medicaex.com/prnewswire/sanyou-biopharmaceuticals-opens-cambridge-ma-us-office-expanding-its-business-outreach-to-a-central-hub-of-biotech-network/ 2023-03-06T06:12:17+00:00 https://medicaex.com/prnewswire/luxury-membership-5-stars-medical-club-embraces-web-3-0-in-tie-up-with-medical-blockchain-project-care/ 2023-03-05T23:12:15+00:00 https://medicaex.com/prnewswire/qurient-co-ltd-and-tb-alliance-announce-exclusive-license-agreement-for-telacebec-q203-a-new-anti-tuberculosis-agent/ 2023-03-05T06:12:12+00:00 https://medicaex.com/prnewswire/new-contactless-health-monitoring-technology-anura-enables-mobile-carriers-and-handset-developers-to-integrate-digital-health-solution/ 2023-03-03T14:12:20+00:00 https://medicaex.com/prnewswire/111-to-announce-fourth-quarter-and-fiscal-year-2022-unaudited-financial-results-conference-call-to-follow/ 2023-03-03T14:12:15+00:00 https://medicaex.com/prnewswire/global-times-small-and-mid-sized-cities-in-china-go-through-infection-peak-bearing-new-hope-for-future/ 2023-03-03T14:12:12+00:00 https://medicaex.com/prnewswire/exocobio-obtained-2-gmp-licenses-for-exosome-biopharmaceuticals-from-korea-mfds-and-for-hyaluronic-acid-ha-dermal-fillers-from-brazil-anvisa/ 2023-03-03T06:12:14+00:00 https://medicaex.com/prnewswire/med-el-presents-world-cochlear-implant-day-2023-over-45-years-of-major-technological-advances-that-enhance-hearing-and-quality-of-life/ 2023-03-03T01:12:19+00:00 https://medicaex.com/prnewswire/debiopharm-extends-their-dna-damage-repair-footprint-with-new-oncology-pipeline-entry/ 2023-03-03T01:12:14+00:00 https://medicaex.com/prnewswire/global-times-having-weathered-epidemic-storms-overseas-chinese-return-to-hometown-for-safe-joyous-spring-festival-reunions/ 2023-03-02T13:12:14+00:00 https://medicaex.com/prnewswire/remidios-revolutionary-ai-on-a-smartphone-for-referable-diabetic-retinopathy-dr-receives-eu-mdr-class-ii-regulatory-approval/ 2023-03-02T12:12:23+00:00 https://medicaex.com/prnewswire/national-comprehensive-cancer-network-updates-annual-conference-with-new-in-person-venue-hybrid-format-expert-led-sessions-highlighted-research-perspectives-and-small-group-conversations/ 2023-03-02T12:12:18+00:00 https://medicaex.com/prnewswire/cambrex-recognized-with-cdmo-leadership-awards-for-9th-consecutive-year/ 2023-03-02T12:12:18+00:00 https://medicaex.com/prnewswire/a-promising-picture-for-multi-cancer-early-detection-in-southeast-asia-latest-update-from-biotech-firm-gene-solutions/ 2023-03-02T10:12:19+00:00 https://medicaex.com/prnewswire/amplify-health-asia-pte-limited-appoints-dr-axel-baur-as-chief-executive-officer/ 2023-03-02T08:12:19+00:00 https://medicaex.com/prnewswire/global-cold-chain-transport-track-trace-revenues-in-pharma-to-reach-us2-9-billion-by-2027/ 2023-03-02T06:12:16+00:00 https://medicaex.com/prnewswire/crt-2023-selects-syntach-cardiac-support-system-for-best-innovation-competition/ 2023-03-01T20:12:30+00:00 https://medicaex.com/prnewswire/oricell-closes-45m-series-b1-financing-to-expand-development-of-key-products/ 2023-03-01T20:12:22+00:00 https://medicaex.com/prnewswire/the-sigourney-award-trust-issues-call-for-entries-of-psychoanalytic-work-eligible-to-win-the-sigourney-award-2023/ 2023-03-01T14:12:17+00:00 https://medicaex.com/prnewswire/maternity-and-baby-brand-momcozy-launches-parachute-care-program-to-support-breastfeeding-journeys/ 2023-03-01T14:12:17+00:00 https://medicaex.com/prnewswire/gracell-biotechnologies-to-participate-in-oppenheimer-33rd-annual-healthcare-conference/ 2023-03-01T13:12:25+00:00 https://medicaex.com/prnewswire/commercialization-of-gene-therapy-is-coming-soon-neurophth-completes-patient-enrollment-for-phase-iii-clinical-trial-for-the-gene-therapy-treatment-of-lhon/ 2023-03-01T11:12:47+00:00 https://medicaex.com/prnewswire/global-sarcoma-therapy-now-approved-for-new-zealand-patients/ 2023-03-01T11:12:32+00:00 https://medicaex.com/prnewswire/chulas-aicute-an-assessment-tool-for-ischemic-stroke-risk/ 2023-03-01T11:12:30+00:00 https://medicaex.com/prnewswire/meihua-international-medical-technologies-co-ltd-enters-into-cooperation-agreements-with-hainans-qionghai-city-and-hainan-free-trade-port-boao-hope-city-to-build-technology-park-and-medical-resea/ 2023-03-01T08:12:43+00:00 https://medicaex.com/prnewswire/fat-hope-shou-be-it-fat-hope-official-opens-at-bugis-junction/ 2023-03-01T08:12:42+00:00 https://medicaex.com/prnewswire/pulnovo-medical-reports-positive-one-year-results-for-padn-cfda-trial-in-pulmonary-arterial-hypertension-pah-treatment/ 2023-03-01T08:12:36+00:00 https://medicaex.com/prnewswire/ew-nutrition-showcases-customer-focused-solutions-for-the-animal-nutrition-industry-at-viv-asia-2023/ 2023-03-01T07:12:19+00:00 https://medicaex.com/prnewswire/on-rare-disease-day-2023-remegen-highlights-its-social-responsibility-and-rare-disease-advocacy/ 2023-03-01T01:12:25+00:00 https://medicaex.com/prnewswire/amaris-b-clinic-awarded-the-body-sculpting-medical-centre-of-the-year-in-asia-pacific-for-four-years-in-a-row-by-globalhealth-asia-pacific-2/ 2023-03-01T01:12:24+00:00 https://medicaex.com/prnewswire/gc-biopharma-signs-agreement-with-catalyst-biosciences-for-the-acquisition-of-rare-disease-pipeline-in-hematology/ 2023-03-01T00:12:23+00:00 https://medicaex.com/prnewswire/new-study-shows-glycomark-test-identifies-prediabetic-individuals-with-the-highest-risk-of-developing-diabetes-before-symptoms-develop/ 2023-02-28T15:12:47+00:00 https://medicaex.com/prnewswire/help-therapeutics-announces-ind-approval-of-first-universal-ipsc-derived-cardiomyocyte-therapy-for-end-stage-heart-failure-in-china/ 2023-02-28T15:12:31+00:00 https://medicaex.com/prnewswire/img-named-a-best-travel-insurance-company-of-2023-by-forbes-advisor/ 2023-02-28T15:12:17+00:00 https://medicaex.com/prnewswire/innovent-announces-first-participant-dosed-in-phase-1-clinical-study-of-ibi333-vegf-a-vegf-c-bispecific-fusion-protein-in-patients-with-neovascular-age-related-macular-degeneration/ 2023-02-28T13:12:32+00:00 https://medicaex.com/prnewswire/everest-medicines-hosts-ceremony-to-celebrate-commencement-of-operations-at-its-state-of-the-art-mrna-vaccine-manufacturing-facility/ 2023-02-28T13:12:32+00:00 https://medicaex.com/prnewswire/jw-therapeutics-announces-initiation-of-clinical-study-of-jwatm214-in-patients-with-advanced-hepatocellular-carcinoma/ 2023-02-28T10:12:33+00:00 https://medicaex.com/prnewswire/eluminex-biosciences-closes-40-million-series-b-financing-to-continue-the-development-of-innovative-ophthalmic-assets-and-recombinant-human-collagen-technology/ 2023-02-28T09:12:27+00:00 https://medicaex.com/prnewswire/gracell-biotechnologies-to-report-fourth-quarter-2022-financials-on-monday-march-13-2023/ 2023-02-28T04:12:26+00:00 https://medicaex.com/prnewswire/over-90-of-adults-above-the-age-of-50-carry-the-virus-that-causes-shingles-yet-only-3-of-singaporeans-in-this-age-group-believe-they-are-at-high-risk-of-developing-the-disease/ 2023-02-28T02:12:22+00:00 https://medicaex.com/prnewswire/cstone-announces-chinas-nmpa-has-accepted-the-supplementary-new-drug-application-of-sugemalimab-as-first-line-treatment-for-patients-with-locally-advanced-or-metastatic-gastric-gastroesophageal-junc/ 2023-02-28T01:12:22+00:00 https://medicaex.com/prnewswire/japans-omi-medical-center-seikoukai-becomes-the-first-healthcare-organization-in-western-japan-to-sign-a-partnership-agreement-with-trinetx-to-increase-participation-in-multi-national-clinical-tri/ 2023-02-27T23:12:25+00:00 https://medicaex.com/prnewswire/igene-laboratory-announces-launch-of-whole-exome-sequencing-service/ 2023-02-27T18:12:35+00:00 https://medicaex.com/prnewswire/distinguished-acupuncturist-in-china-zhaohui-zhang-publishes-paper-on-neuromodulation-as-the-corresponding-author/ 2023-02-27T18:12:28+00:00 https://medicaex.com/prnewswire/ascletis-1672-hk-included-in-the-hang-seng-hong-kong-listed-biotech-index/ 2023-02-27T10:12:37+00:00 https://medicaex.com/prnewswire/edan-pictured-the-long-term-regional-development-plans-with-the-minister-counselor-of-the-chinese-embassy-in-kenya/ 2023-02-27T09:14:05+00:00 https://medicaex.com/prnewswire/china-pharma-holdings-inc-announces-1-for-10-reverse-stock-split/ 2023-02-27T09:13:27+00:00 https://medicaex.com/prnewswire/european-wellness-group-european-society-of-preventive-regenerative-anti-aging-medicine-launches-a-handbook-of-anti-aging-medicine-for-physicians/ 2023-02-27T09:13:26+00:00 https://medicaex.com/prnewswire/global-times-so-much-better-than-we-had-anticipated-chinas-rural-regions-embrace-spring-festival-as-covid-peak-ebbs-away/ 2023-02-27T09:13:22+00:00 https://medicaex.com/prnewswire/rvac-medicines-secures-hsa-approval-to-initiate-phase-1b-clinical-trial-in-singapore/ 2023-02-27T08:12:51+00:00 https://medicaex.com/prnewswire/porton-advanced-and-yinjia-biosciences-partner-to-enhance-cdmo-technology-platform/ 2023-02-27T08:12:33+00:00 https://medicaex.com/prnewswire/telix-2022-full-year-results-revenue-up-20x-in-first-year-of-commercial-sales-underpins-transition-to-cash-flow-positive/ 2023-02-27T07:12:29+00:00 https://medicaex.com/prnewswire/dr-lilly-xu-named-president-of-shanghai-chempartner/ 2023-02-27T05:12:24+00:00 https://medicaex.com/prnewswire/bridge-biotherapeutics-presents-phase-2a-clinical-trial-results-for-bbt-401-a-drug-candidate-to-treat-ulcerative-colitis/ 2023-02-27T01:12:38+00:00 https://medicaex.com/prnewswire/detailed-results-from-telixs-zircon-phase-iii-kidney-cancer-imaging-study-presented-at-asco-gu/ 2023-02-27T01:12:38+00:00 https://medicaex.com/prnewswire/lunit-to-establish-subsidiary-in-europe-to-accelerate-business-expansion/ 2023-02-27T01:12:32+00:00 https://medicaex.com/prnewswire/qilian-received-notification-of-deficiency-from-nasdaq-related-to-not-timely-filing-of-annual-report-form-20-f/ 2023-02-27T01:12:25+00:00 https://medicaex.com/prnewswire/havas-health-you-and-the-american-parkinson-disease-association-launch-sexual-wellness-campaign-parkinsex/ 2023-02-27T01:12:25+00:00 https://medicaex.com/prnewswire/tb-alliance-announces-david-norton-as-board-chair/ 2023-02-27T01:12:25+00:00 https://medicaex.com/prnewswire/invivoscribe-diagnostic-technologies-shanghai-co-ltd-receives-cap-accreditation-to-support-clinical-research-testing-for-pharmaceutical-partners-in-china/ 2023-02-26T19:14:15+00:00 https://medicaex.com/prnewswire/inventia-life-science-collaborates-with-msd-to-develop-3d-advanced-cell-models-for-neurodegenerative-disease-drug-discovery/ 2023-02-24T14:12:40+00:00 https://medicaex.com/prnewswire/servier-receives-a-positive-chmp-opinion-for-tibsovo-in-idh1-mutated-acute-myeloid-leukemia-aml-and-cholangiocarcinoma-cca-patients/ 2023-02-24T14:12:25+00:00 https://medicaex.com/prnewswire/zhongchao-inc-renews-partnership-with-johnson-johnson-china/ 2023-02-24T14:12:25+00:00 https://medicaex.com/prnewswire/structo-announces-a-new-generation-of-dental-3d-printers-powered-by-msla-2-0-for-superior-total-cost-of-ownership/ 2023-02-24T14:12:16+00:00